This article is freely available to all

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: There is a burgeoning literature associating movement disorders with selective serotonin reuptake inhibitors (SSRIs). However, most of these reports are composed of cases of extrapyramidal symptoms (EPS) such as akathisia, dystonia, and parkinsonism,1,2 not dyskinesias. Dyskinesias, traditionally associated with antipsychotics, are rare with SSRIs.1‘ ‹